Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-12 Earnings release - Q3 2026

More about the company

Market Cap	116M 12.4M 10.74M 10.14M 9.2M 17.25M 1.19B 17.38M 121M 46.65M 603M 46.56M 45.54M 1.92B	P/E 2026 *	-0.81x	P/E 2027 *	-1.77x
Enterprise Value	107M 11.43M 9.91M 9.35M 8.48M 15.91M 1.1B 16.02M 112M 43.02M 556M 42.94M 41.99M 1.77B	EV / Sales 2026 *	107x	EV / Sales 2027 *	-
Free-Float	65.56%	Yield 2026 *	-	Yield 2027 *	-

09-14	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
09-10	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI
08-31	Ocean GeoLoop Subsidiary to Sell Ocean Tunicell Stake to Lifecare	MT
08-19	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-19	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT
06-26	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
06-18	An undisclosed buyer signed a non-binding agreement to acquire Ocean Tunicell AS from Ocean GeoLoop AS (OB:OCEAN).	CI
06-10	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
05-15	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
05-15	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-15	Lifecare Q1 operating loss NOK 31.5 mln	RE

08-19	Lifecare : Interim Report Q2 2026 Presentation	PU
08-19	LIFE: Lifecare ASA Q2 2026 results	PU
08-12	Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST	AQ
07-02	LIFE: Update on production transfer and longevity programme	AQ
06-26	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	06/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	31/03/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	29/02/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	25/06/2020
Morten Foros Krohnstad CHM	Chairman	-	07/05/2021
Lutz Heinemann BRD	Director/Board Member	-	19/11/2020

Lifecare AS Share Price Oslo Bors

Stocks

NO0010591191

Biotechnology & Medical Research

Valuation: Lifecare AS

Latest news: Lifecare AS

Last Transcript: Lifecare AS

Analysts' recommendations: Lifecare AS

Press Releases: Lifecare AS

News in other languages: Lifecare AS

Managers and Directors: Lifecare AS

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE AS	-.--%	-4.31%	-	-	12.42M
LONZA GROUP AG	+0.56%	-4.71%	-2.45%	+9.18%	45.48B
REVOLUTION MEDICINES, INC.	+0.66%	-2.34%	+340.62%	+530.14%	43.68B
IQVIA HOLDINGS INC.	+1.49%	-0.78%	+41.90%	+24.75%	43.09B
BEONE MEDICINES AG	+2.11%	-1.24%	+9.09%	+78.25%	39.4B
CELLTRION, INC.	+0.34%	-4.03%	+9.34%	+38.90%	31.91B
ASCENDIS PHARMA A/S	+0.53%	-2.08%	-	-	17.31B
MEDPACE HOLDINGS, INC.	+1.34%	+0.70%	+21.35%	+112.62%	16.4B
EUROFINS SCIENTIFIC SE	+2.07%	+0.78%	+13.07%	+30.91%	14.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.85%	-5.33%	+78.63%	+31.45%	13.28B
Average	+0.72%	-2.42%	+63.95%	+107.03%	29.42B
Weighted average by Cap.	+0.94%	-2.83%	+76.00%	+127.96%

	2026 *	2027 *
Net sales	1M 107K 92.93K 87.7K 79.56K 149K 10.28M 150K 1.05M 404K 5.21M 403K 394K 16.58M	-
Net income	-109M -11.69M -10.13M -9.56M -8.67M -16.27M -1.12B -16.39M -114M -43.99M -568M -43.91M -42.94M -1.81B	-67M -7.19M -6.23M -5.88M -5.33M -10M -689M -10.07M -70.18M -27.04M -349M -26.99M -26.39M -1.11B
Net Debt	-9M -965K -836K -789K -716K -1.34M -92.52M -1.35M -9.43M -3.63M -46.93M -3.63M -3.55M -149M	4M 429K 372K 351K 318K 597K 41.12M 601K 4.19M 1.61M 20.86M 1.61M 1.58M 66.32M